Diagnosing Alzheimer’s Disease – Project granted with more than €1.3 million in aid under the Colaboración Público Privada Program
Destina Genomica SL is part of a consortium formed by the Foundation for Biomedical Research of the Ramón y Cajal…
Destina Genomica SL is part of a consortium formed by the Foundation for Biomedical Research of the Ramón y Cajal…
We are excited to announce a new project that changes the way we analyze miRNA-122. This small non-coding RNA is…
DESTINA Genomics and Mecwins join forces to develop more reliable diagnostic tests Both biotechnology firms have signed a cross-licensing…
On Wednesday 31 March 2021, DESTINA’s Juan Jose Diaz-Mochon will present the First Single Molecule Counting (SMC™) Application with miRNAs by a…
Citation: Talanta, 2020, doi: 10.1016/j.talanta.2020.121265 Abstract Dynamic chemical labelling is a single-base specific method to enable detection and quantification of micro-Ribonucleic…
Granada 12th October 2020 I was a Spanish academic researcher living in the UK who always wanted to commercialise some…